期刊
ACS NANO
卷 14, 期 3, 页码 2847-2859出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.9b06168
关键词
degradable carbon-silica nanocomposite; patient-derived xenograft tumor model; immunoadjuvant property; photothermal therapy; photodynamic therapy
类别
资金
- National Key Research and Development Program of China [2016YFA0201503]
- National Natural Science Foundation of China [21822802, 51772018, 51572271, 21304006, 51972343]
- Fundamental Research Funds for the Central Universities [buctrc201915, PYBZ1825, XK1802-8]
- CAMS Innovation Fund for Medical Sciences [2016-I2M-1-007, 2018-I2M-1-002]
Carbon nanomaterials have flourished for cancer therapy for decades. However, their practical applications on clinical bases still pose a challenge to address the dilemma of metabolism in vivo. In this study, an attempt is made to design a degradable carbon-silica nanocomposite (CSN) with immunoadjuvant property, which could undergo an enzyme-free degradation process into small particles (similar to 5 nm) and facilitate its clinical application. CSN harbors photothermal and photodynamic properties and as an immunoadjuvant would help to generate tumor-associated antigens and mature dendritic cells (DCs). Potent antitumor effects have been achieved in both 4T1 and patient-derived xenograft tumor models with tumor inhibition efficiencies of 93.2% and 92.5%, respectively. We believe that this strategy will benefit the possible clinical translation and carbon-silica-nanomaterial-based cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据